최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Journal of pharmaceutical sciences : a publication of the American Pharmaceutical Association, v.104 no.10, 2015년, pp.3544 - 3556
Elnaggar, Yosra S. R. (Department of Pharmaceutics, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt) , Etman, Samar M. (Department of Pharmaceutics, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt) , Abdelmonsif, Doaa A. (Department of Medical Biochemistry, Faculty of Medicine, Alexandria University, Alexandria, Egypt) , Abdallah, Ossama Y. (Department of Pharmaceutics, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt)
Piperine (PIP) is a phytopharmaceutical with reported neuroprotective potential in Alzheimer's disease (AD). Oral PIP delivery suffers from its hydrophobicity and pre‐systemic metabolism. In this article, mono‐disperse intranasal chitosan nanoparticles (CS‐NPs) were elaborated for ...
Prince M , Bryce R , Albanese E , Wimo A , Ribeiro W , Ferri CP . 2013 . The global prevalence of dementia: A systematic review and metaanalysis . Alzheimers Dement 9 ( 1 ): 63 – 75 e62 .
Desai AK , Schwartz L , Grossberg GT . 2012 . Behavioral disturbance in dementia . Curr Psychiatry Rep 14 ( 4 ): 298 – 309 .
Hebert LE , Scherr PA , Bienias JL , Bennett DA , Evans DA . 2003 . Alzheimer disease in the US population: Prevalence estimates using the 2000 census . Arch Neurol 60 ( 8 ): 1119 – 1122 .
Hoyer S . 2000 . Brain glucose and energy metabolism abnormalities in sporadic Alzheimer disease. Causes and consequences: An update . Exp Gerontol 35 ( 9–10 ): 1363 – 1372 .
Matsuyama SS , Jarvik LF . 1989 . Hypothesis: Microtubules, a key to Alzheimer disease . Proc Natl Acad Sci USA 86 ( 20 ): 8152 – 8156 .
Flaherty CF , Rowan GA , Emerich DF , Walsh TJ . 1989 . Effects of intrahippocampal administration of colchicine on incentive contrast and on radial maze performance . Behav Neurosci 103 ( 2 ): 319 – 328 .
Calabrese V , Butterfield DA , Stella AM . 2003 . Nutritional antioxidants and the heme oxygenase pathway of stress tolerance: Novel targets for neuroprotection in Alzheimer's disease . Ital J Biochem 52 ( 4 ): 177 – 181 .
Kontush K , Schekatolina S . 2004 . Vitamin E in neurodegenerative disorders: Alzheimer's disease . Ann N Y Acad Sci 1031 : 249 – 262 .
Qizilbash N , Birks J , Lopez Arrieta J , Lewington S , Szeto S . 2007 . WITHDRAWN: Tacrine for Alzheimer's disease . Cochrane Database Syst Rev ( 3 ): CD000202 .
Chonpathompikunlert P , Wattanathorn J , Muchimapura S . 2010 . Piperine, the main alkaloid of Thai black pepper, protects against neurodegeneration and cognitive impairment in animal model of cognitive deficit like condition of Alzheimer's disease . Food Chem Toxicol 48 ( 3 ): 798 – 802 .
Gupta SK , Bansal P , Bhardwaj RK , Velpandian T . 2000 . Comparative anti‐nociceptive, anti‐inflammatory and toxicity profile of nimesulide vs nimesulide and piperine combination . Pharmacol Res 41 ( 6 ): 657 – 662 .
D'Hooge R , Pei YQ , Raes A , Lebrun P , van Bogaert PP , de Deyn PP . 1996 . Anticonvulsant activity of piperine on seizures induced by excitatory amino acid receptor agonists . Arzneimittelforschung 46 ( 6 ): 557 – 560 .
Lai LH , Fu QH , Liu Y , Jiang K , Guo QM , Chen QY , Yan B , Wang QQ , Shen JG . 2012 . Piperine suppresses tumor growth and metastasis in vitro and in vivo in a 4T1 murine breast cancer model . Acta Pharmacol Sin 33 ( 4 ): 523 – 530 .
Lee SA , Hong SS , Han XH , Hwang JS , Oh GJ , Lee KS , Lee MK , Hwang BY , Ro JS . 2005 . Piperine from the fruits of Piper longum with inhibitory effect on monoamine oxidase and antidepressant‐like activity . Chem Pharm Bull (Tokyo) 53 ( 7 ): 832 – 835 .
Wattanathorn J , Chonpathompikunlert P , Muchimapura S , Priprem A , Tankamnerdthai O . 2008 . Piperine, the potential functional food for mood and cognitive disorders . Food Chem Toxicol 46 ( 9 ): 3106 – 3110 .
Yusuf M , Khan M , Khan RA , Ahmed B . 2013 . Preparation, characterization, in vivo and biochemical evaluation of brain targeted Piperine solid lipid nanoparticles in an experimentally induced Alzheimer's disease model . J Drug Target 3 ( 21 ): 300 – 311 .
Aroonsri Priprem PC , Saengrawee Sutthiparinyanont , Jintanaporn Wattanathorn . 2011 . Antidepressant and cognitive activities of intranasal piperine‐encapsulated liposomes . Adv Biosci Biotechnol 2 : 108 – 116 .
Costantino HR , Illum L , Brandt G , Johnson PH , Quay SC . 2007 . Intranasal delivery: Physicochemical and therapeutic aspects . Int J Pharm 337 ( 1–2 ): 1 – 24 .
Nakamura K , Maitani Y , Lowman AM , Takayama K , Peppas NA , Nagai T . 1999 . Uptake and release of budesonide from mucoadhesive, pH‐sensitive copolymers and their application to nasal delivery . J Control Release 61 ( 3 ): 329 – 335 .
Illum L . 2004 . Is nose‐to‐brain transport of drugs in man a reality? J Pharm Pharmacol 56 ( 1 ): 3 – 17 .
Sastre J , Mosges R . 2012 . Local and systemic safety of intranasal corticosteroid . J Investig Allergol Clin Immunol 22 : 1 – 12 .
Mistry A , Stolnik S , Illum L . 2009 . Nanoparticles for direct nose‐to‐brain delivery of drugs . Int J Pharm 379 ( 1 ): 146 – 157 .
Yoshino T , Machida Y , Onishi H , Nagai T . 2003 . Preparation and characterization of chitosan microspheres containing doxifluridine . Drug Dev Ind Pharm 29 ( 4 ): 417 – 427 .
Nagpal K , Singh SK , Mishra DN . 2013 . Optimization of brain targeted chitosan nanoparticles of Rivastigmine for improved efficacy and safety . Int J Biol Macromol 59 : 72 – 83 .
Pavinatto A , Pavinatto FJ , Barros‐Timmons A , Oliveira ON Jr . 2010 . Electrostatic interactions are not sufficient to account for chitosan bioactivity . ACS Appl Mater Interfaces 2 ( 1 ): 246 – 251 .
Illum L , Farraj NF , Davis SS . 1994 . Chitosan as a novel nasal delivery system for peptide drugs . Pharm Res 11 ( 8 ): 1186 – 1189 .
Kim MS , You HJ , You MK , Kim NS , Shim BS , Kim HM . 2004 . Inhibitory effect of water‐soluble chitosan on TNF‐alpha and IL‐8 secretion from HMC‐1 cells . Immunopharmacol Immunotoxicol 26 ( 3 ): 401 – 409 .
Amidi M , Romeijn SG , Borchard G , Junginger HE , Hennink WE , Jiskoot W . 2006 . Preparation and characterization of protein‐loaded N‐trimethyl chitosan nanoparticles as nasal delivery system . J Control Release 111 ( 1–2 ): 107 – 116 .
Vaka SR , Shivakumar HN , Repka MA , Murthy SN . 2013 . Formulation and evaluation of carnosic acid nanoparticulate system for upregulation of neurotrophins in the brain upon intranasal administration . J Drug Target 21 ( 1 ): 44 – 53 .
Prashant Sahu AB , Chaurasia Anand , Gajbhiye Virendra . 2012 . Higher therapautic benefits of piperine loaded optimized chitosan microspheres for improved hepatoprotective potentials . Res Gate Pharm Sci 1 ( 1 ): 39 – 44 .
Elnaggar YS , El‐Massik MA , Abdallah OY . 2011 . Sildenafil citrate nanoemulsion vs. self‐nanoemulsifying delivery systems: Rational development and transdermal permeation . Int J Nanotechnol 8 ( 8 ): 749 – 763 .
Rajpal V . 2002 . Piper Nigrum . Standardization of botanicals . New Delhi : Eastern Publications , pp. 258 , 267 .
Calvo P , Remunan‐Lopez C , Vila‐Jato JL , Alonso MJ . 1997 . Chitosan and chitosan/ethylene oxide‐propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines . Pharm Res 14 ( 10 ): 1431 – 1436 .
Vila A , Sanchez A , Tobio M , Calvo P , Alonso MJ . 2002 . Design of biodegradable particles for protein delivery . J Control Release 78 ( 1–3 ): 15 – 24 .
Aktas Y , Andrieux K , Alonso MJ , Calvo P , Gursoy RN , Couvreur P , Capan Y . 2005 . Preparation and in vitro evaluation of chitosan nanoparticles containing a caspase inhibitor . Int J Pharm 298 ( 2 ): 378 – 383 .
Elnaggar YS , El‐Massik MA , Abdallah OY . 2011 . Fabrication, appraisal, and transdermal permeation of sildenafil citrate‐loaded nanostructured lipid carriers versus solid lipid nanoparticles . Int J Nanomed 6 : 3195 – 3205 .
Freag MS , Elnaggar YS , Abdallah OY . 2013 . Lyophilized phytosomal nanocarriers as platforms for enhanced diosmin delivery: Optimization and ex vivo permeation . Int J Nanomed 8 : 2385 – 2397 .
Fazil M , Md S , Haque S , Kumar M , Baboota S , Sahni JK , Ali J . 2012 . Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting . Eur J Pharm Sci 47 ( 1 ): 6 – 15 .
D'Hooge R , De Deyn PP . 2001 . Applications of the Morris water maze in the study of learning and memory . Brain Res Brain Res Rev 36 ( 1 ): 60 – 90 .
Ganguly R , Guha D . 2008 . Alteration of brain monoamines & EEG wave pattern in rat model of Alzheimer's disease & protection by Moringa oleifera . Indian J Med Res 128 ( 6 ): 744 – 751 .
Veerendra Kumar MH , Gupta YK . 2002 . Intracerebroventricular administration of colchicine produces cognitive impairment associated with oxidative stress in rats . Pharmacol Biochem Behav 73 ( 3 ): 565 – 571 .
Terry AV Jr . 2009 . Spatial navigation (water maze) tasks . In Buccafusco JJ , editor. Methods of behavior analysis in neuroscience . 2nd ed . Taylor & Francis Group, LLC Boca Raton, Florida .
Wills ED . 1966 . Mechanisms of lipid peroxide formation in animal tissues . Biochem J 99 ( 3 ): 667 – 676 .
Koracevic D , Koracevic G , Djordjevic V , Andrejevic S , Cosic V . 2001 . Method for the measurement of antioxidant activity in human fluids . J Clin Pathol 54 ( 5 ): 356 – 361 .
Kono Y . 1978 . Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase . Arch Biochem Biophys 186 ( 1 ): 189 – 195 .
Woodruff‐Pak DS , Tobia MJ , Jiao X , Beck KD , Servatius RJ . 2006 . Preclinical investigation of the functional effects of memantine and memantine combined with galantamine or donepezil . Neuropsychopharmacology 32 ( 6 ): 1284 – 1294 .
Ellman GL , Courtney KD , Andres V Jr. , Feather‐Stone RM . 1961 . A new and rapid colorimetric determination of acetylcholinesterase activity . Biochem Pharmacol 7 : 88 – 95 .
Casciola‐Rosen L , Nicholson DW , Chong T , Rowan KR , Thornberry NA , Miller DK , Rosen A . 1996 . Apopain/CPP32 cleaves proteins that are essential for cellular repair: A fundamental principle of apoptotic death . J Exp Med 183 ( 5 ): 1957 – 1964 .
Tiwari V , Chopra K . 2011 . Resveratrol prevents alcohol‐induced cognitive deficits and brain damage by blocking inflammatory signaling and cell death cascade in neonatal rat brain . J Neurochem 117 ( 4 ): 678 – 690 .
Lowry OH , Rosebrough NJ , Farr AL , Randall RJ . 1951 . Protein measurement with the Folin phenol reagent . J Biol Chem 193 ( 1 ): 265 – 275 .
Chan YH . 2003 . Biostatistics 102: Quantitative data–parametric & non‐parametric tests . Singapore Med J 44 ( 8 ): 391 – 396 .
Kotz S BN , Read CB , Vidakovic B . 2006 . Encyclopedia of statistical sciences . Hobojen, New Jersey : John Wiley & Sons .
Elnaggar YS , El‐Refaie WM , El‐Massik MA , Abdallah OY . 2014 . Lecithin‐based nanostructured gels for skin delivery: An update on state of art and recent applications . J Control Release 180 : 10 – 24 .
Elsheikh MA , Elnaggar YS , Gohar EY , Abdallah OY . 2012 . Nanoemulsion liquid preconcentrates for raloxifene hydrochloride: Optimization and in vivo appraisal . Int J Nanomed 7 : 3787 – 3802 .
Freag MS , Elnaggar YS , Abdallah OY . 2013 . Development of novel polymer‐stabilized diosmin nanosuspensions: In vitro appraisal and ex vivo permeation . Int J Pharm 454 ( 1 ): 462 – 471 .
Elsheikh MA , Elnaggar YS , Abdallah OY . 2014 . Rationale employment of cell culture versus conventional techniques in pharmaceutical appraisal of nanocarriers . J Control Release 194 : 92 – 102 .
El‐Refaie WM , Elnaggar YS , El‐Massik MA , Abdallah OY . 2015 . Novel curcumin‐loaded gel‐core hyaluosomes with promising burn‐wound healing potential: Development, in‐vitro appraisal and in‐vivo studies . Int J Pharm 486 ( 1–2 ): 88 – 98 .
Elnaggar YS . 2015 . Multifaceted implementations of bile salts in pharmacy: An emphasis on nanomedicine. Int . J. Nanomed 10 : 1 – 17 .
El‐Refaie WM , Elnaggar YS , El‐Massik MA , Abdallah OY . 2015 . Novel self‐assembled, gel‐core hyaluosomes for non‐invasive management of osteoarthritis: In‐vitro optimization, ex‐vivo and in‐vivo permeation . Pharm Res . 32 ( 4 ).
Calvo P , Remu˜nán‐López C , Vila‐Jato JL , Alonso MJ . 1997 . Novel hydrophilic chitosan–polyethylene oxide nanoparticles as protein carriers . J Appl Poly Sci 63 : 125 – 132 .
Sharma TASaCP . 2011 . Chitosan and its derivatives for drug delivery perspective . Adv Polym Sci ( 243 ): 30 .
Xu Y , Du Y . 2003 . Effect of molecular structure of chitosan on protein delivery properties of chitosan nanoparticles . Int J Pharm 250 ( 1 ): 215 – 226 .
Zhang X , Sun M , Zheng A , Cao D , Bi Y , Sun J . 2012 . Preparation and characterization of insulin‐loaded bioadhesive PLGA nanoparticles for oral administration . Eur J Pharm Sci 45 ( 5 ): 632 – 638 .
Kumar A , Seghal N , Naidu PS , Padi SS , Goyal R . 2007 . Colchicines‐induced neurotoxicity as an animal model of sporadic dementia of Alzheimer's type . Pharmacol Rep 59 ( 3 ): 274 – 283 .
Kumar A , Dogra S , Prakash A . 2009 . Neuroprotective effects of centella asiatica against intracerebroventricular colchicine‐induced cognitive impairment and oxidative stress . Int J Alzheimers Dis 2009 : 972178 .
O Choi A , Maysinger D . 2013 . Intranasal fluorescent nanocrystals for longitudinal in vivo evaluation of cerebral microlesions . Pharm Nanotechnol 1 ( 2 ): 93 – 104 .
Riedel G , Platt B , Micheau J . 2003 . Glutamate receptor function in learning and memory . Behav Brain Res 140 ( 1–2 ): 1 – 47 .
Halliwell B , Gutteridge JM , Cross CE . 1992 . Free radicals, antioxidants, and human disease: Where are we now? J Lab Clin Med 119 ( 6 ): 598 – 620 .
Massaad CA , Klann E . 2011 . Reactive oxygen species in the regulation of synaptic plasticity and memory . Antioxid Redox Signal 14 ( 10 ): 2013 – 2054 .
Husain K , Somani SM . 1997 . Interaction of exercise training and chronic ethanol ingestion on hepatic and plasma antioxidant system in rat . J Appl Toxicol 17 ( 3 ): 189 – 194 .
Kusano C , Ferrari B . 2008 . Total antioxidant capacity: A biomarker in biomedical and nutritional studies . J Cell Mol Biol 7 ( 1 ): 16 .
Prado VF , Martins‐Silva C , de Castro BM , Lima RF , Barros DM , Amaral E , Ramsey AJ , Sotnikova TD , Ramirez MR , Kim HG , Rossato JI , Koenen J , Quan H , Cota VR , Moraes MF , Gomez MV , Guatimosim C , Wetsel WC , Kushmerick C , Pereira GS , Gainetdinov RR , Izquierdo I , Caron MG , Prado MA . 2006 . Mice deficient for the vesicular acetylcholine transporter are myasthenic and have deficits in object and social recognition . Neuron 51 ( 5 ): 601 – 612 .
Dai J , Buijs RM , Kamphorst W , Swaab DF . 2002 . Impaired axonal transport of cortical neurons in Alzheimer's disease is associated with neuropathological changes . Brain Res 948 ( 1–2 ): 138 – 144 .
Roberson MR , Harrell LE . 1997 . Cholinergic activity and amyloid precursor protein metabolism . Brain Res Brain Res Rev 25 ( 1 ): 50 – 69 .
Smith A , Perelman M , Hinchcliffe M . 2014 . Chitosan: A promising safe and immune‐enhancing adjuvant for intranasal vaccines . Hum Vaccin Immunother 10 ( 3 ): 797 – 807 .
Hawkins BT , Davis TP . 2005 . The blood‐brain barrier/neurovascular unit in health and disease . Pharmacol Rev 57 ( 2 ): 173 – 185 .
Liu Z , Gastard M , Verina T , Bora S , Mouton PR , Koliatsos VE . 2001 . Estrogens modulate experimentally induced apoptosis of granule cells in the adult hippocampus . J Comp Neurol 441 ( 1 ): 1 – 8 .
Kumar A , Seghal N , Padi SV , Naidu PS . 2006 . Differential effects of cyclooxygenase inhibitors on intracerebroventricular colchicine‐induced dysfunction and oxidative stress in rats . Euro J pharmacol 551 ( 1 ): 58 – 66 .
Md S , Khan RA , Mustafa G , Chuttani K , Baboota S , Sahni JK , Ali J . 2013 . Bromocriptine loaded chitosan nanoparticles intended for direct nose to brain delivery: Pharmacodynamic, pharmacokinetic and scintigraphy study in mice model . Eur J Pharm Sci 48 ( 3 ): 393 – 405 .
Wang X , Chi N , Tang X . 2008 . Preparation of estradiol chitosan nanoparticles for improving nasal absorption and brain targeting . Euro J Pharm Biopharm 70 ( 3 ): 735 – 740 .
Al‐Ghananeem AM , Saeed H , Florence R , Yokel RA , Malkawi AH . 2009 . Intranasal drug delivery of didanosine‐loaded chitosan nanoparticles for brain targeting; an attractive route against infections caused by aids viruses . J Drug Target 18 ( 5 ): 381 – 388 .
Friedman AJ , Phan J , Schairer DO , Champer J , Qin M , Pirouz A , Blecher‐Paz K , Oren A , Liu PT , Modlin RL , Kim J . 2013 . Antimicrobial and anti‐inflammatory activity of chitosan‐alginate nanoparticles: A targeted therapy for cutaneous pathogens . J Invest Dermatol 133 ( 5 ): 1231 – 1239 .
Oliveira MI , Santos SG , Oliveira MJ , Torres AL , Barbosa MA . 2012 . Chitosan drives anti‐inflammatory macrophage polarisation and pro‐inflammatory dendritic cell stimulation . Eur Cell Mater 24 : 136 – 152 ; discussion 152–133.
Yang E‐J , Kim J‐G , Kim J‐Y , Kim S , Lee N , Hyun C‐G . 2010 . Anti‐inflammatory effect of chitosan oligosaccharides in RAW 264.7 cells . Centl Euro J Biol 5 ( 1 ): 95 – 102 .
Rinwa P , Kumar A , Garg S . 2013 . Suppression of neuroinflammatory and apoptotic signaling cascade by curcumin alone and in combination with piperine in rat model of olfactory bulbectomy induced depression . PLoS One 8 ( 4 ): e61052 .
Shrivastava P , Vaibhav K , Tabassum R , Khan A , Ishrat T , Khan MM , Ahmad A , Islam F , Safhi MM , Islam F . 2013 . Anti‐apoptotic and anti‐inflammatory effect of Piperine on 6‐OHDA induced Parkinson's rat model . J Nutr Biochem 24 ( 4 ): 680 – 687 .
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.